US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

66.40

-0.5220-0.78%

Post-market: 66.19-0.2080-0.31%19:30 EDT

Volume:24.85K

Turnover:1.65M

Market Cap:99.91M

PE:- -

High:66.96

Open:66.96

Low:66.07

Close:66.92

52wk High:68.00

52wk Low:37.25

Shares:1.50M

Float Shares:1.50M

Volume Ratio:0.98

T/O Rate:1.65%

Dividend:0.65

Dividend Rate:0.98%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

uniQure seeks accelerated approval for Huntington’s gene therapy

uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

Guardant Health Price Target Maintained with a $195.00/Share by BTIG

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Moderna to Present at Morgan Stanley Global Healthcare Conference

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

Natera announces publication of new data in Blood Neoplasia on Signatera

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

Circio boosts circVec gene therapy data and secures funding runway to 2030

Cboe data suggests bullish flow in Moderna with shares up 0.71%

Moderna Stock (MRNA) Was the Best Performer in August

CytoDyn Net Loss Widens to $42.7 Million in FY26

Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/GNOM/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":66.398,"timestamp":1789761600000,"preClose":66.92,"halted":0,"volume":24845,"hourTrading":{"tag":"盘后","latestPrice":66.19,"preClose":66.398,"latestTime":"19:30 EDT","volume":17,"amount":1127.886,"timestamp":1789774206560,"change":-0.208,"changeRate":-0.003133,"amplitude":0},"delay":0,"changeRate":-0.007800358637178804,"floatShares":1504713,"shares":1504713,"eps":0,"marketStatus":"Market Closed","change":-0.522,"latestTime":"09-18 16:00:00 EDT","open":66.96,"high":66.96,"low":66.066,"amount":1649200.1682,"amplitude":0.013359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":66.92,"sharesOutstanding":1094672,"nav":66.45,"aum":99990068.69,"dividendRate":0.009765,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":68.03,"preClose":66.92,"latestTime":"07:44 EDT","volume":1,"amount":68.03,"timestamp":1789731862440,"change":1.11,"changeRate":0.016587,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":66.19,"preClose":66.398,"latestTime":"19:30 EDT","volume":17,"amount":1127.886,"timestamp":1789774206560,"change":-0.208,"changeRate":-0.003133,"amplitude":0},"volumeRatio":0.9764734550142276,"impliedVol":0.3077,"impliedVolPercentile":0.8048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1504713,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9764734550142276,"shares":1504713,"dividePrice":0.6484,"high":66.96,"amplitude":0.013359,"preClose":66.92,"low":66.066,"week52Low":37.25,"pbRate":"--","week52High":68,"institutionHeld":0,"latestPrice":66.398,"eps":0,"divideRate":0.009765,"volume":24845,"delay":0,"ttmEps":0,"open":66.96,"prevYearClose":45.4562,"prevWeekClose":62.2188,"prevMonthClose":64.4209,"prevQuarterClose":56.834,"fiveDayClose":62.2188,"twentyDayClose":64.9029,"sixtyDayClose":53.7792},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664878125","title":"Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878125","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878125?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:21","pubTimestamp":1788427316,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $108, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","BK4533","MRNA","BK4588","MRNY","GNOM","WDNA","BK4139","BK4548","BK4551","IDNA","LGHT","BK4532","BK4501","MRNX","BK4568","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664982743","title":"Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664982743","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664982743?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:20","pubTimestamp":1788423613,"startTime":"0","endTime":"0","summary":"Transgene jumps 20% on positive cancer vaccine data in early trialSept 3 (Reuters)-TransgeneTRNG.PAshares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL6N44V0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4533","MRNA","BK4588","MRNY","GNOM","WDNA","BK4139","BK4548","BK4551","IDNA","LGHT","BK4532","BK4501","MRNX","BK4568","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819175","title":"uniQure seeks accelerated approval for Huntington’s gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819175?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350375,"startTime":"0","endTime":"0","summary":"The latest update is out from uniQure ( ($QURE) ). On September 2, 2026, uniQure submitted a Biologics License Application to the U.S. Food and Dru...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","BK4588","TBXU","FBT","GNOM","BK4585","LFSC","CNCR","SYNB","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664150698","title":"uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664150698","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664150698?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:05","pubTimestamp":1788347100,"startTime":"0","endTime":"0","summary":"~ Company also announces the submission of a Marketing Authorisation Application for ifezuntirgene inilparvovec in the U.K. ~ ~ Both submissions are supported by the three-year data analysis from the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354993/0/en/uniqure-announces-submission-of-biologics-license-application-for-ifezuntirgene-inilparvovec-amt-130-in-huntington-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DTCR","REAI","BK4585","BK4534","IDGT","WTRE","AMT","BK4588","GNOM","BYRE","BK4554","SPRE","LU0320765992.SGD","LABU","BK4139","PSR","QURE","XLRE","MAA","DTRE","FREL","ICF","SRVR","LU0889565916.HKD","VNQ","AVRE","BK4084","LU0109394709.USD","CRED","BK4219","URE","HELS","BK4581","DFGR","TRUR","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818611","title":"Guardant Health Price Target Maintained with a $195.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818611?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:52","pubTimestamp":1788342720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GNOM","BK4585","LU0889565916.HKD","LFSC","LU0320765992.SGD","EKG","BK4196","GNMX","HELX","PTH","BK4535","BK4551","GH","FFOX","LU0109394709.USD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664486915","title":"Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2664486915","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664486915?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:37","pubTimestamp":1788295066,"startTime":"0","endTime":"0","summary":"Moderna plans private placement of $2 billion convertible senior notes due 2032Moderna launched a private placement of USD 2 billion Convertible Senior Notes due 2032, marketed to qualified institutio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL75wNqt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDNA","MRNY","BK4568","WDNA","BK4585","BK4533","BK4551","BK4588","BK4548","BK4501","MRNA","LGHT","MRNX","BK4534","GNOM","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664901869","title":"Moderna Inc. Stock Advances 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664901869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664901869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:33","pubTimestamp":1788294780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.This was the stock's second consecutive day of gains.Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0289739699.SGD","BBH","TMED","IBB","BK4568","BK4566","LU0109394709.USD","BK4583","GILD","BK4533","MRNX","TBXU","LU2112291526.USD","LU1066053197.SGD","WDNA","LU1430594728.SGD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU0965509010.AUD","LU1934455863.HKD","BIB","MRNA","LGHT","IDNA","LU1934455277.USD","LU2468319806.SGD","BK4534","IBBQ","LU0861579265.USD","LU0058720904.USD","LU1037948541.HKD","MEDI","BK4139","BMED","BK4501","SG9999015945.SGD","LU1057294990.SGD","GNOM","LU1571399168.USD","LU0234570918.USD","LU0965508806.USD","LU0320765992.SGD","LU0823416689.USD","LU1934455194.USD","MRNY","BK4551","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863257","title":"Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863257","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664863257?lang=en_us&edition=fundamental","pubTime":"2026-09-02 01:40","pubTimestamp":1788284405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Guardant Health (GH) with bullis...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-medtronic-mdt-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","LU1116320737.USD","LU1989771016.USD","LU0265550946.USD","LU1983299246.USD","IE000M9KFDE8.USD","LU1244550221.USD","LABU","GNMX","LU0158827781.USD","BK4535","LU1571399168.USD","XLV","LFSC","LU2028103732.USD","LU0211331839.USD","LU0072461881.USD","LU0162691827.USD","IE00BQXX3C00.GBP","LU2089283258.USD","LU1061106388.HKD","LU0109394709.USD","LU2089284900.SGD","BK4082","LU0889565916.HKD","IE00BQXX3F31.USD","LU1989764748.USD","IE00B3PB1722.GBP","FFOX","HCSG","LU2023251221.USD","PTH","EKG","GNOM","LU0106261372.USD","XBI","LU0320765489.SGD","LU2271345857.HKD","LU0432979614.USD","GH","IE00BFXG1179.USD","LU1506573853.SGD","LU0208291251.USD","HELX","LU1291159041.SGD","MDT","LU0128526141.USD","LU0976567544.SGD","LU0211326755.USD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664500918","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2664500918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664500918?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:00","pubTimestamp":1788278413,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeModerna, Inc.MRNA.OQ+6.2%Mosaic CoMOS.N+4.2%Dollar Tree IncDLTR.OQ+3.8%Corteva, Inc.CTVA.N+3.6%Dollar General CorpDG.N+3.4%Bottom PerformersPercent ChangeAxon Enterprise, Inc.AXON.OQ-9.1%CrowdStrike Holdings, Inc.CRWD.OQ-6.9%Cadence Design Systems, Inc.CDNS.OQ-5.6%Ciena CorporationCIEN.N-5.4%Palo Alto Networks, Inc.PANW.OQ-5.3%As of 12:00 p.m., the S&P 500.SPXlost 25.96 points, or 0.34%, to 7,660.18 and had posted 7 new 52-week highs and 10 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL8N44T1PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHAK","LGHT","SPAM","CIEG","MRNY","IDNA","WDNA","PALU","PSWD","IGV","BUG","MRNX","CIBR","MRNA","VEGI","CDNS","EYES","MOS","PANW","CRWD","AIPI","PANG","WCBR","CRWL","FOTO","XTL","CRWC","GNOM","CDNG","DG","XAR","CIEN","CTVA","LU0724618433.USD","HAKY","CLOD","CIEX","KROP","DLTR","AXUP","FTAG","AIFD","RSPS","PBJ","PALD","GUNZ","AXON","PYZ","WCLD","IE00B5949003.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856780","title":"Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856780","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856780?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:06","pubTimestamp":1788264367,"startTime":"0","endTime":"0","summary":"Guardant Health Shield blood test wins Carelon coverage for colorectal cancer screeningGuardant Health secured Carelon Healthcare Services coverage for its FDA-approved Shield blood test for colorecta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL9hPZ6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","PTH","LU0889565916.HKD","HELX","FFOX","BK4588","GNOM","BK4535","BK4196","BK4585","EKG","BK4551","GNMX","LU0109394709.USD","LFSC","GDOC","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","XLV","BK4581","XBI","LU0128526141.USD","GNOM","BK4139","IBBQ","LFSC","MEDI","TBXU","SYNB","LU0029874061.USD","BK4505","HCSG","LABU","FBT","MEMS","CNCR","BK4585","CANC","BK4588","BK4137","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083853","title":"Moderna to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083853","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083853?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:06","pubTimestamp":1788260801,"startTime":"0","endTime":"0","summary":"Moderna to present at Morgan Stanley Global Healthcare ConferenceModerna will present at the Morgan Stanley Global Healthcare Conference on Sept. 14, 2026 at 10:00 a.m. ET.It will also present at the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8XX49W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2357305700.SGD","LU1988902786.USD","LU0795875086.SGD","LGHT","MRNY","IDNA","LU2347655156.SGD","BK4501","WDNA","LU2111349929.HKD","MRNX","BK4504","LU0557290698.USD","MRNA","IE00B775SV38.USD","LU1720051108.HKD","LU0267386448.USD","BK4532","LU0882574139.USD","LU1244550577.SGD","BK4585","LU1548497426.USD","LU2264538146.SGD","LU0795875169.SGD","BK4588","LU0912757837.SGD","BK4548","LU1720051017.SGD","LU2028103732.USD","LU0106261372.USD","IAI","LU0225283273.USD","LU0158827948.USD","LU2023251221.USD","LU1791710582.SGD","IE00BZ1G4Q59.USD","LU1064131342.USD","LU0106831901.USD","KBWB","LU1732799900.SGD","LU1989772840.SGD","LU1989772923.USD","LU0320765646.SGD","BK4533","LU1791710400.SGD","GNOM","BK4516","LU0390134368.USD","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664985383","title":"Novartis halts autoimmune CAR-T trials following three deaths, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664985383","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664985383?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258648,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after thr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-halts-autoimmune-car-t-trials-following-three-deaths-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","IBBQ","FBT","CNCR","NVIB","NVS","BK4532","BK4007","PPH","SYNB","IE0002141913.USD","TBXU","BK4588","IE0009355771.USD","IDNA","GDOC","HYLG","BK4585","LFSC","MEDX","IE00BJJMRZ35.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","BMED","GNOM","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IBB","LU0211331839.USD","LU0208291251.USD","BK4578","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853895","title":"Natera announces publication of new data in Blood Neoplasia on Signatera","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853895?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:25","pubTimestamp":1788258359,"startTime":"0","endTime":"0","summary":"Natera (NTRA) announced the publication of new data in Blood Neoplasia, validating the prognostic and predictive value of Signatera in patients wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-announces-publication-of-new-data-in-blood-neoplasia-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-announces-publication-of-new-data-in-blood-neoplasia-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0345770993.USD","LU0345770308.USD","HELX","LU0106261612.USD","LU2264538146.SGD","LU0963586101.USD","LU0053671581.USD","LU0012050646.USD","NTRA","GNOM","LU2065169927.USD","LU2324357040.USD","LU2065731478.USD","LU2065171311.SGD","LU2065170008.USD","LU1064131342.USD","LU2065171402.SGD","BK4139","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664836115","title":"Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836115","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664836115?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:51","pubTimestamp":1788245470,"startTime":"0","endTime":"0","summary":"TradingKey - In August 2026, the upward momentum in US stocks broadened significantly. Moderna (MRNA) topped the S&P 500 constituents with a 156% gain, surging 375.9% year-to-date. Palantir (PLTR) followed closely behind, rising 51.5% in August, while enterprise software stocks as a whole extended their previous recovery.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230915/5159981a89101d628f3e4c33ac20272e.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262143172-top-10-best-performing-us-stocks-august-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366333091.USD","LU0265550359.USD","LU2089284900.SGD","LU2125909916.SGD","MRNY","LU0158827781.USD","SMCY","LU0053671581.USD","LU0081259029.USD","LU0300736062.USD","BK4134","LU1046421795.USD","IE0002270589.USD","LU2271345857.HKD","LU2357305700.SGD","LU0006306889.USD","LU0310799852.SGD","BK4167","BK4548","LU0477156797.USD","LU1023059493.AUD","PLT","LU1496350171.SGD","QQQG","TRUM","LU0823434583.USD","PLTA","LU0496367417.USD","PLTZ","DISK","BK4551","IE00BQXX3F31.USD","PLTY","LU0130102774.USD","LU1551013342.USD","LU0054578231.USD","LU2125909759.SGD","LU0251142724.SGD","LU1153585028.USD","LU1861215975.USD","LU0082616367.USD","LGHT","VEEV","IE00B19Z9Z06.USD","LU0158827948.USD","BK4504","LU2063271972.USD","LU2089283258.USD","BK4566","AUAU","LU0187121727.USD","LU2517655291.USD","LU0154245756.USD","LU0234570918.USD","LU0278409577.USD","BK4568","LU2028103732.USD","IE00B19Z8W00.USD","BK4613","BK4527","LU0266512127.USD","LU1804176565.USD","IE00BKVL7J92.USD","SCHA","LU0820561909.HKD","LU0320765059.SGD","LU0472753341.HKD","LU0823434740.USD","MRNX","LU0345780950.USD","LU1923622614.USD","SMCI","BK4125","IE00BMPRXN33.USD","LU0612318385.USD","LU1720051108.HKD","SNDC","SCHM","LU0889565833.HKD","LU0345781412.USD","IE00BJTD4N35.SGD","LU0348723411.USD","LU0234572021.USD","PLTW","GUNZ","LU0788108826.HKD","SMCX","LU2543165471.USD","PTIR","PLYY","LU1223082519.USD","LU1548497426.USD","LU0289739343.SGD","LU0654597011.USD","LU0238689110.USD","LU1989764748.USD","LU2517655374.HKD","GNOM","LU1551013425.SGD","BK4170","LU0069063385.USD","LU0316494557.USD","LU1923622291.USD","BK4501","LU1861220033.SGD","SNXX","PLOO","LU1223083913.SGD","LU0314104364.USD","LU0368265764.SGD","LU0310800965.SGD","SNDG","IE00BMPRXR70.SGD","LU1883866441.USD","LU0266512473.USD","LU0052756011.USD","IE00BQXX3C00.GBP","LU0289961442.SGD","LU2433249047.HKD","SG9999001143.SGD","PLTD","LU0058720904.USD","IE00BZ9MQY76.HKD","LU0265550946.USD","LU1814569148.SGD","LU0106261372.USD","BK4503","LU1430597077.USD","SNDQ","LU1988902786.USD","LU1861559042.SGD","LU0055631609.USD","IGV","BK4097","LU0048573561.USD","LU0943347566.SGD","LU2125909593.SGD","BK4607","LU0211327993.USD","LU0353189763.USD","LU2106854487.HKD","LU2023250843.SGD","SPLTRmain","WDNA","LU1064131342.USD","LU0477156953.USD","BK4538","LU1989764664.SGD","IE00BZ1G4Q59.USD","LU1989772840.SGD","BK4023","LU0708995401.HKD","PLTR","CRM","LU0011850046.USD","LU0057025933.USD","BK4581","GDMN","CRMG","LU2458330169.SGD","LU0198837287.USD","BK4533","LU0889566641.SGD","LU0124676726.USD","TMSL","LU2236285917.USD","PLTI","LU0792757196.USD","LU1116320901.HKD","LU1803068979.SGD","LU1720051017.SGD","LU2381873111.SGD","LU0724618789.USD","LU2290526834.HKD","LU0211328371.USD","LU1201861249.SGD","BK4608","SLVP","FMTL","LU0075056555.USD","NOW","AIPI","BK4532","LU2360107168.USD","BK4567","BK4139","LU2264538146.SGD","LU2247934214.USD","LU1267930813.SGD","LU0154245673.USD","LU2125909247.SGD","BK4543","LU0128525689.USD","LU0498741114.HKD","SMYY","LU1791710582.SGD","SMCL","IE00BQXX3D17.EUR","BK4528","LU0511384066.AUD","LU2286300806.USD","LU1316542783.SGD","LU2461242641.AUD","NOWL","LU0107464264.USD","LU1989772923.USD","LU2498475776.HKD","LU0672654240.SGD","LU0130518102.USD","NWMX","LU1861558580.USD","LU1323610961.USD","LU1201861165.SGD","IDNA","LU0130517989.USD","EKG","LU0980610538.SGD","LU0648001328.SGD","LU0557290698.USD","LU0345780281.USD","BK4505","LU0498741890.SGD","PTF","CNAV","BK4585","LU2362541513.USD","LU1267930490.SGD","NOWX","LU0648000940.SGD","LU0157215616.USD","IE00BJTD4V19.USD","FSMD","LU0820561818.USD","LU1791710400.SGD","PLTU","LU0719512351.SGD","LU0170899867.USD","COWG","PSKY","SMCC","LU2458330243.SGD","LU0689626769.HKD","LU1951198990.SGD","LU1823568750.SGD","SNDU","IE00B19Z9505.USD","LU0689472784.USD","LU2361044949.HKD","LU0963586101.USD","IE00B19Z3B42.SGD","FCUS","LU2361044865.SGD","LU2361045086.USD","LU1496350502.SGD","LU2756315318.SGD","LU1235294995.USD","LU0642271901.SGD","BK4017","BK4547","LU0630314457.HKD","PLTG","NEM","AGMI","BK4570","LU0130103400.USD","LU0353189680.USD","LU0742534661.SGD","GDX","NEMG","BK4598","BK4588","LU2023251221.USD","LU0640476718.USD","SNDK","LU0289739699.SGD","IE00B894F039.SGD","LU0127658192.USD","LU2517655028.SGD","LU2023250504.SGD","LU1923623000.USD","LU0300736492.USD","BK4561","LU1267930227.SGD","OPTZ","LU2756315664.SGD","CLOD","LU0456854461.SGD","LU2087625088.SGD","BK4535","IE00B19Z8X17.USD","SHLD","LU0345780521.USD","PLTL","BK4534","MRNA","LU0528227936.USD","IT","LU1280957306.USD","LU0354030511.USD","BK4579","LU0267386448.USD","LU0612318971.USD","LU1974910355.USD","EYES","SMCZ","BK4550","LU0251131958.USD","IE00B19Z3581.USD","LU2362540622.SGD","LU0109392836.USD","LU0354030438.USD","LU1223082196.USD","LU0109391861.USD","LU2362541273.HKD","LU0820562030.AUD","LU1267930730.SGD","LU2111349929.HKD","LU2265009873.SGD","LU2462611646.USD","LU0330918003.SGD","LU2244417387.USD","LU1951200564.SGD","LU0788109121.HKD","LU0266013472.USD","SGDM","IE00B19Z9P08.USD","LU1917777945.USD","LU1116320737.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","TBXU","RNA","GNOM","IBB","CNCR","BK4505","FBT","IE0009354923.USD","LFSC","IBBQ","BK4585","SYNB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000652","title":"Cboe data suggests bullish flow in Moderna with shares up 0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000652?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:20","pubTimestamp":1788200410,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Moderna (MRNA), with shares up 98c, or 0.71%, near $138.97. Options volume relatively light with 62k contracts t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-0-71-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-0-71-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4501","BK4532","MRNA","MRNX","LGHT","BK4139","WDNA","BK4588","GNOM","MRNY","BK4568","BK4551","IDNA","BK4548","BK4533","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664200767","title":"Moderna Stock (MRNA) Was the Best Performer in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664200767","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664200767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:18","pubTimestamp":1788196728,"startTime":"0","endTime":"0","summary":"Moderna’s ($MRNA) stock rose 152% in August, making it the best-performing security during the month.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-stock-mrna-was-the-best-performer-in-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","GNOM","BK4139","LGHT","WDNA","MRNA","BK4585","BK4568","BK4501","BK4532","BK4551","BK4588","MRNX","MRNY","IDNA","BK4533","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663039950","title":"CytoDyn Net Loss Widens to $42.7 Million in FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2663039950","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663039950?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:35","pubTimestamp":1788179703,"startTime":"0","endTime":"0","summary":"CytoDyn net loss widens to $42.7 million in FY26CytoDyn posted a net loss of $42.7 million, swinging from net income of $3.7 million a year earlier.Operating loss widened to $38.6 million as operating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbc0jH6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU0345770308.USD","HELX","LU0106261612.USD","LU2264538146.SGD","LU0963586101.USD","LU0053671581.USD","LU0012050646.USD","NTRA","GNOM","LU2065169927.USD","LU2324357040.USD","LU2065731478.USD","LU2065171311.SGD","CYDY","LU2065170008.USD","LU1064131342.USD","LU2065171402.SGD","BK4139","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044590","title":"Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044590","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044590?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:19","pubTimestamp":1788088793,"startTime":"0","endTime":"0","summary":"In August 2026, Guardant Health said it would appeal a US District Court of Delaware final judgment in a patent dispute with TwinStrand Biosciences and the University of Washington, with execution of the judgment and collection of potential royalties paused during the appeal.\nThe court’s royalty order applies mainly to older Guardant tests, while Guardant reports that upgraded versions of key products such as Shield and Reveal, along with validated design changes to Guardant360, fall outside...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/does-guardant-healths-gh-patent-appeal-reshape-its-competiti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/does-guardant-healths-gh-patent-appeal-reshape-its-competiti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GNMX","PTH","HELX","GH","LU0320765992.SGD","BK4535","GNOM","BK4588","GDOC","LU0889565916.HKD","LFSC","BK4585","LU0109394709.USD","EKG","FFOX","BK4196","BK4551"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}